Numerous studies have suggested relationships between myeloperoxidase (MPO), inflammation, and atherosclerosis. MPO-derived reactive chlorinating species attack membrane plasmalogens releasing ␣-chloro fatty aldehydes including 2-chlorohexadecanal (2-ClHDA), which have been found to accumulate in activated neutrophils, activated monocytes, infarcted myocardium and human atheromas. The present study employed synthetically prepared 2-Cl- 
Phagocytes are important mediators of host defense mechanisms against microbes (1) (2) (3) . The concomitant release of myeloperoxidase (MPO) 2 with its substrate, H 2 O 2 , by phagocytes results in the production of the reactive chlorinating species (RCS), hypochlorous acid (HOCl), which is a bactericidal agent (4) . The production of HOCl by MPO amplifies the oxidizing potential of reactive oxygen species produced by the phagocyte respiratory burst (2) . HOCl elicits its antimicrobial actions and cytotoxicity by targeting multiple critical molecules including proteins, nucleic acids, and lipids (5) (6) (7) (8) (9) (10) (11) (12) (13) . For example, HOCl reacts with primary amine-containing molecules, resulting in the production of the more stable RCS, monochloramines and dichloramines (14) . Tyrosine residues of proteins can also be targeted by RCS resulting in 3-chlorotyrosine (15, 16) . In addition to the antimicrobial actions of MPO-derived HOCl, it also targets host tissues and likely participates in the pathophysiological sequelae of several cardiovascular diseases, including atherosclerosis and myocardial ischemia-reperfusion injury (17) (18) (19) (20) (21) (22) . Recently, RCS have been shown to target the plasmalogen molecular subclass of phospholipids, resulting in the unmasking of the plasmalogenic vinyl ether aliphatic group as an ␣-chloro fatty aldehyde (23) . This halogenated aldehyde accumulates in both human atherosclerotic lesions and infarcted rat myocardium (17, 18) . Furthermore, at physiological concentrations, ␣-chloro fatty aldehyde is a chemoattractant and has been shown to elicit cardiac injury and ventricular dysfunction (18, 24) . The accumulation of ␣-chloro fatty aldehyde in atherosclerotic lesions and in infarcted myocardium, coupled with the potential role this lipid may have on cardiovascular function, underscore the importance of determining the mechanisms responsible for ␣-chloro fatty aldehyde catabolism.
Many aldehydes found in vivo are produced through free radical mechanisms. The cytotoxicity of aldehydes is attenuated by reduction, oxidation, or conjugation with glutathione (25) (26) (27) (28) (29) (30) . Aldehyde dehydrogenase oxidizes the aldehyde to its carboxylic acid. Human liver microsomal aldehyde dehydrogenase is specific for medium-and long-chain fatty aldehydes (31) . A mutation in this fatty aldehyde dehydrogenase has been linked to Sjögren-Larsson syndrome (32) . Alternatively, longchain fatty aldehydes can be reduced to their respective fatty alcohols (33) (34) (35) . Additionally, aldehydes can diffuse within, or escape from, their cells of origin and form covalent adducts with proteins and phospholipids. Reactive aldehydes have been shown to react with primary amines on proteins to form Schiff base adducts and Michael addition products (formed by the nucleophilic attack on an ␣,␤-unsaturated aldehyde such as 4-hydroxynonenal). In fact, 4-hydroxynonenal has been shown to covalently modify low density lipoprotein apolipoproteins contributing to the formation of a high uptake form of low density lipoprotein and to form protein adducts during ischemia-reperfusion injury (36, 37) . Another aldehyde, p-hydroxyphenylacetaldehyde, a product of MPO oxidation of L-tyrosine, forms Schiff base adducts with aminophospholipids of low density lipoprotein (38) , which are present in human atherosclerotic tissues (39) .
Understanding the metabolism of ␣-chloro fatty aldehyde may be critical in revealing the role of this novel plasmalogen oxidation product in cardiovascular disease. Accordingly, the present study was designed to elucidate the metabolism of the ␣-chloro fatty aldehyde, 2-chlorohexadecanal (2-ClHDA). The results herein demonstrate that both endothelial cells and neutrophils oxidize and reduce 2-ClHDA to its respective chlorinated fatty acid and chlorinated fatty alcohol, which are subsequently incorporated into complex glycerolipids. 16 :0 FA were subjected to ␣-chlorination with chlorine(g) using the Hell-VolhardZelinsky reaction and phosphorous as the catalyst (40) . Briefly, 16:0 FA was melted at 80°C before an equimolar amount of phosphorous trichloride in dichloromethane was added to the reaction vial. Chlorine(g) was then slowly bubbled into the reaction mixture for 1 h. The crude product was sequentially extracted using a modified Bligh and Dyer method (41), TLC-purified (silica gel G TLC plates with a mobile phase composed of petroleum ether/ethyl ether/acetic acid (70/30/1, v/v/v) (R F ϭ 0.24)), and then further purified on a Thermo Finnigan Surveyor liquid chromatograph equipped with a Beckman RP Ultrasphere TM ODS (5 , 4.6 mm ϫ 25 cm) column coupled to a TSQ Quantum Ultra triple quadrupole mass spectrometer. Products were eluted at a flow rate of 2 ml/min from the stationary phase with a mobile phase composed of 85/15 MeOH/H 2 O containing 0.02% formic acid (A) for 3 min followed by a linear gradient from 100% A to 100% MeOH (B) over 7 min. The solid phase was further eluted with 100% B for 10 min. The LC eluate was split 10:1, and the LCpurified reaction products were detected by electrospray ionizationmass spectrometry using selected ion monitoring 3 H]-HDA that was resolved on TLC plates was detected by fluorography. In brief, the developed TLC plates were treated with EN 3 HANCE spray (PerkinElmer Life Sciences) prior to exposure to x-ray film (Kodak) at Ϫ80°C. Alternatively, parallel TLC plates or lanes (on TLC plates) were developed with lipid standards, and silica from regions associated with specific lipids was scraped from the plate. Radioactivity was quantified by liquid scintillation spectrometry. Additionally, silica associated with regions of TLC plates detected by fluorography was also scraped from the plate and quantified by liquid scintillation spectrometry.
EXPERIMENTAL PROCEDURES
(SIM) of m/z 289 ([M Ϫ H] Ϫ of 2-Cl-16:0 FA) or m/z 293 ([M Ϫ H] Ϫ of [d 4 ]2-
␣-Chloro Fatty Aldehyde Metabolism
Chlorinated Fatty Alcohols-TLC-purified chlorinated fatty alcohols were converted to their respective pentafluorobenzoyl esters using 2,3,4,5,6-pentafluorobenzoyl chloride (PFB-Cl) at 60°C for 45 min (45) . GC-MS analysis of PFB esters was performed using a Hewlett Packard (Palo Alto, CA) 6890 gas chromatograph and 5973 mass spectrometer using the negative ion chemical ionization mode with methane as the reagent gas. The source temperature was set at 150°C. The electron energy was 240 eV, and the emission current was 300 mA. The PFB derivatives were separated on a J & W Scientific (Folsom, CA) DB-1 column (12.5 m, 0.2 mm inner diameter, 0.33 mm film thickness). The injector and the transfer line temperatures were maintained at 250°C. The GC oven was maintained at 150°C for 3.5 min, increased at a rate of 30°C/min to 270°C, and held at 270°C for an additional 2 min.
Chlorinated 1, 3, and 5) . Images of the charring and autoradiography were overlaid. B, 2-Cl- [ 3 H]-HDA was subjected to TLC and fluorography to enhance the detection of potential minor contaminants. methanolysis. The resultant 2-ClFAME and FAME was analyzed by TLC and fluorography.
RESULTS

Synthetic 2-Cl-[ 3 H]-HDA-2-Cl-[
3 H]-HDA was synthesized, purified, and used to elucidate ␣-chloro fatty aldehyde metabolism in both HCAEC and neutrophils. (Fig. 2) . These experiments demonstrated that 2-ClHDA was taken up rapidly by HCAEC, and radiolabel derived from 2-ClHDA was eventually incorporated into complex glycerolipids in the HCAEC, including phosphatidylcholine and phosphatidylethanolamine. Radiolabel in these complex glycerolipids remained in the HCAEC and was not released. Additionally, radiolabel derived from 2-ClHDA was found in the ␣-chloro fatty alcohol (␣-ClFOH) and ␣-chloro fatty acid (␣-ClFA) pools of the cells, as well as these same lipid pools in the cell culture medium (Fig. 2) .
2-Cl-[
3 H]-HDA was not metabolized by cell culture medium without cells present (data not shown). Thus, these results revealed that radiolabeled 2-ClHDA is readily oxidized and reduced to fatty acids and fatty alcohols, respectively, in the cells and that these metabolites are released from the cells. It is likely that the radiolabeled fatty acid is incorporated into the complex glycerolipids. The temporal course of the incorporation of radiolabel from 2-Cl-[
3 H]-HDA into cellular lipid pools is shown in greater detail in Fig. 3 . For these experiments, lipid classes were separated by one-dimensional TLC using mobile phases that separate either neutral or polar lipid classes. After 2-Cl-[ 3 H]-HDA enters the HCAEC, it is rapidly reduced to ␣-ClFOH within the first hour of labeling (Fig. 3, inset) . Radiolabel also is found in the ␣-ClFA pool within the first hour. Fig. 3B shows the incorporation of the radioactivity derived from 2-Cl-[
3 H]-HDA into the polar lipid pools. The majority of the radioactivity in the polar lipid pools is associated with phosphatidylcholine, and this appears after the first hour of radiolabeling, which suggests that 2-Cl-[
3 H]-HDA is first oxidized to fatty acids prior to its incorporation into phosphatidylcholine. It should be noted that the migrations of ␣-ClFA and ␣-ClFOH using TLC are considerably different from non-chlorinated FA and FOH. The assignment of radiolabel to ␣-ClFA and ␣-ClFOH is based on the co-migration of radiolabel during TLC with regions of authentic ␣-ClFA and ␣-ClFOH. Using a mobile phase of petroleum ether/ethyl ether/acetic acid (70/30/1) and a silica gel 60 solid phase, the R F for FA and ␣-ClFA are 0.34 and 0.24, respectively. The attenuation of ␣-ClFA migration on TLC compared with FA is likely because of the electron-withdrawing properties of the ␣-chlorine on the carbanion of the carboxylic group, thus reducing its pK a .
Additional studies were performed to determine the metabolism of 2-ClHDA within the range of concentrations that have been observed in neutrophils (24) . Fig. 4 shows that the temporal course of 0.1, 1, and 10 M 2-ClHDA metabolism in HCAEC is very similar. At each concentration of 2-ClHDA, radiolabel was incorporated into both the cellular ␣-ClFOH and ␣-ClFA pools followed by the incorporation of radiolabel into complex glycerolipids. At 10 M 2-ClHDA compared with 0.1 and 1 M 2-ClHDA, there was increased radiolabel in the cellular 2-ClHDA pool over the first hour of labeling, and more label was incorporated into sphingomyelin.
Pulse-chase experiments demonstrated that radiolabel derived from 2-Cl- [ 3 H]-HDA is found predominantly in the cellular ␣-ClFOH pool throughout the 1-day chase interval (following a 30-min pulse labeling interval) (Fig. 5A) . ␣-ClFA is also found in the cell during the chase interval but at lower levels compared with ␣-ClFOH (Fig. 5A) . The predominant polar lipids that contain radiolabel during the chase interval are the choline glycerophospholipids and the serine (or inositol) glycerophospholipids (Fig. 5B) . The predominant radiolabel released into the cell culture medium during the chase interval is ␣-ClFOH (Fig. 5C) .
Metabolism of 2-Cl-[ 3 H]-HDA in Human Neutrophils-Because neutrophils produce 2-ClHDA when activated, 2-Cl-[
3 H]-HDA metabolism was assessed in stimulated and unstimulated neutrophils. Similar to HCAEC, radiolabel derived from 2-Cl- [ 3 H]-HDA is incorporated into the ␣-ClFOH and ␣-ClFA pools of the neutrophils soon after uptake into the neutrophils (Fig. 6) . Within 1 h, the radiolabel appears in the phosphatidylcholine pool. The predominant difference between 2-ClHDA metabolism in unstimulated and stimulated neutrophils was observed following 15 min of radiolabeling with 2-ClHDA. Less radioactivity was found in the ␣-ClFA and ␣-ClFOH pools in the stimulated neutrophils as compared with the unstimulated neutrophils (Fig. 6A) . Also, following 15 min of concomitant labeling and phorbol 12-myristate 13-acetate stimulation, there is more radiolabeled 2-ClHDA in the medium in comparison to the unstimulated cells (Fig. 6B) . It is likely that these differences between the stimulated and unstimulated cells is due to the production of endogenous 2-ClHDA in the stimulated neutrophils that dilutes the radiospecific activity of the endogenously added 2-ClHDA. This suggests that exogenously added 2-Cl- [ 3 H]-HDA has access to compartments shared with endogenously produced 2-ClHDA and that the metabolism of the radiolabel is likely similar to that of endogenously produced 2-ClHDA during neutrophil activation.
Metabolite Identification and Confirmation-To further confirm that ␣-ClFOH and ␣-ClFA are metabolites of ␣-ClFALD, additional studies were performed employing stable isotope labeling of HCAEC and mass spectrometric techniques. Fig. 7B shows the mass spectrum of the PFB ester of the ␣-ClFOH, 2-chlorohexadecanol. The parent ion (m/z 470) is accompanied by an ion (m/z 472) that is approximately one-third its intensity, demonstrating that this is a monochlorinated molecule. The GC-MS chromatogram of this derivative is shown in Fig. 7A (␣-ClFOH-standard) using SIM for m/z 470. The PFB ester of 2-chlorohexadecanol is resolved from its non-halogenated analog (FOH-standard, SIM m/z 436). HCAEC that are not treated with 2-ClHDA produce hexadecanol (e.g. m/z 436) but do not produce 2-chlorohexadecanol (e.g. m/z 470) (Fig. 7) . In contrast, HCAEC that are treated with 2-ClHDA produce 2-chlorohexadecanol as well as hexadecanol (cells ϩ 2-ClHDA, Fig. 7 ). As predicted from radiolabeling experiments, 2-chlorohexadecanol is also released into the cell culture medium in cells treated with 2-ClHDA (medium ϩ 2-ClHDA, (Fig. 8) .
Because radiolabeling experiments with 2-Cl-[ 3 H]-HDA resulted in the incorporation of radiolabel into PC, further experiments were performed to characterize the radiolabeled moiety that was incorporated into PC. Lipase treatment of TLC-purified radiolabeled PC from HCAEC incubated with 2-Cl-[ 3 H]-HDA resulted in the release of both radiolabeled fatty acid and radiolabeled ␣-ClFA (Fig. 9A) . Similarly, derivatization of the radiolabeled PC pool by acid methanolysis resulted in the production of the FAME of both FA and 2-Cl-FA (Fig. 9B) . Base methanolysis resulted only in the production of radiolabeled FAME (non-chlorinated). Subsequent analysis 
DISCUSSION
␣-Chloro fatty aldehydes accumulate in both infarcted myocardium and atherosclerotic lesions (17, 18) . Understanding the catabolism of ␣-ClFALD is critical in determining the role of this aldehyde in cardiovascular disease. The present studies have demonstrated that 2-ClHDA is readily oxidized and reduced to ␣-ClFA and ␣-ClFOH, respectively, by HCAEC. In fact, within 30 min of exposure of HCAEC to 2-ClHDA, the intracellular content of 2-ClFOH is greater than that of its precursor, 2-ClHDA. It should also be appreciated that ␣-ClFOH and ␣-ClFA are produced within the cell but are exported out of the cells. These results are in agreement with previous analyses of the metabolism of non-halogenated fatty acids and fatty alcohols, which are metabolites of fatty acid-fatty alcohol cycling pathways with fatty aldehyde as an intermediate (35) . Furthermore, the export of palmitoyl alcohol and palmitic acid out of cells has also been demonstrated in palmitic acid-fed cells (35, 46) . Due to the toxicity of fatty aldehydes to cells, it is likely that this pathway functions to protect the cells. It should be noted that the physiological concentrations of 2-ClHDA used in these studies were below cytotoxic concentrations (Ն50 M, data not shown). The demonstration that ␣-ClFALD is converted to ␣-ClFA and ␣-ClFOH suggests that these metabolites may have important roles in mediating the pathophysiological sequelae of myocardial infarction and atherosclerosis. Alternatively, reduction or oxidation of ␣-ClFALD may represent important mechanisms that protect tissues from further damage by the aldehyde.
The results herein are the first to demonstrate the presence of ␣-ClFA and ␣-ClFOH as biological metabolites of ␣-ClFALD. These metabolites were identified by multiple independent analyses. Both ␣-ClFA and ␣-ClFOH were first identified by the co-migration on TLC of radiolabel from HCAEC labeled with 2-Cl- [ 3 H]-HDA with authentic standards. It was important to compare the migration of these metabolites with authentic chlorinated fatty acid and fatty alcohol, because chlorination of these neutral lipid classes alters their migration on TLC compared with non-chlorinated fatty acid and fatty alcohol. Additionally, niques and stable isotope labeling coupled with fluorography of TLC plates and mass spectrometric techniques to demonstrate the presence of ␣-ClFA and ␣-ClFOH metabolites of ␣-ClFALD.
LC-MS analysis of lipase-treated PC extracted from cells treated with 2-Cl-[d 4 ]-HDA revealed that chlorinated fatty acids derived from 2-ClHDA are incorporated into polar lipids such as PC. The incorporation of ␣-ClFA into PC indicates that ␣-ClFA is converted to its acylCoA counterpart. The presence of ␣-Cl-fatty acyl-CoA in cells suggests that chlorinated fatty acids are incorporated into other lipids. It is speculated that the substitution of a chlorine atom for a hydrogen atom at the ␣ carbon may perturb normal membrane dynamics.
2-ClHDA elicits ventricular dysfunction and cardiac injury and is a neutrophil chemoattractant (18, 24) . Additionally, physiological levels of 2-ClHDA inhibit eNOS protein expression in human umbilical venous endothelial cells (47) . Mechanisms that have been proposed for the loss of eNOS protein, in response to 2-ClHDA, are through mRNA destabilization as well as changes in protein trafficking. Previous studies have shown that 2-ClHDA forms Schiff base adducts with free amines (45) . Those studies suggest that one mechanism for alterations in eNOS trafficking might be due to 2-ClHDA associated with the protein. Alternatively, the present data suggest that 2-ClHDA effects on eNOS expression could also be mediated by the ␣-ClFA or ␣-ClFOH metabolites of ␣-ClFALD (2-ClHDA). Importantly, direct effects of 2-ClHDA on eNOS or indirect effects by ␣-ClFA or ␣-ClFOH metabolites could contribute to pathophysiological changes that may lead to endothelial dysfunction and tissue injury seen in the early phases of atherosclerosis.
Plasmalogens are the precursors of ␣-ClFALD that are released by RCS targeting the vinyl ether-linked aliphatic group attached to the sn-1 carbon of the glycerol backbone. In normal cells that are not subject to RCS attack, the metabolic turnover of the vinyl ether-linked aliphatic group of plasmalogens is ϳ300 times slower than that of the sn-2-esterified fatty acid and the sn-3 polar head group of plasmalogens (42) . The biosynthesis of the vinyl ether bond of plasmalogens is preceded by the biosynthesis of an alkyl ether bond linking the sn-1 aliphatic group to the glycerol backbone. The initial step in the biosynthesis of the alkyl ether bond is through an exchange reaction of fatty alcohol with fatty acid esterified to dihydroxyacetone phosphate (48) . The biosynthesis of cellular fatty alcohol is through the fatty acid-fatty alcohol cycle (35) . It is fascinating that this RCS mechanism that has been shown to chemically target the vinyl ether bond is accompanied by a catabolic mechanism that removes the ␣-ClFALD and produces a ␣-ClFOH that potentially could have an impact on ether-linked lipid biosynthesis. Under the conditions employed in the present study, radiolabel from 2-Cl- [ 3 H]-HDA was only minimally detected in the sn-1 chain of ether-linked lipids, suggesting that the halogenated alcohol is not incorporated into ether-linked lipids. Furthermore, it is possible that ␣-ClFOH inhibits ether-linked lipid biosynthesis. If ␣-ClFOH inhibits ether-linked lipid biosynthesis, then the attack of plasmalogens by RCS could have a dual effect in decreasing the content of this critical membrane lipid through the targeting of the vinyl ether and long term effects through the production of the inhibitor ␣-ClFOH of plasmalogen biosynthesis. The effects of ␣-ClFOH on plasmalogen metabolism remain to be elucidated.
The recent discovery that the plasmalogen vinyl ether bond is targeted by RCS resulting in the production of ␣-ClFALD has led to the hypothesis that this mechanism may have a role in ischemia-reperfusion injury and atherosclerosis. It now seems likely that the targeting of plasmalogens by RCS could have multiple effects on host tissues. One effect would be on the membrane dynamics of the membrane that loses plasmalogens by RCS targeting. Another effect would be from Schiff base adduct formation with ␣-ClFALD and primary amines in the membrane domain from which the ␣-ClFALD originates. Additionally, previous studies have shown ␣-ClFALD and lysophosphatidylcholine may have roles in the chemoattraction and tethering of phagocytes to regions of inflammation (17, 24) . The present study now suggests there is a family of chlorinated lipidic metabolites produced from ␣-ClFALD, and the elucidation of their biological effects may provide important insights into the critical role of plasmalogen oxidation by RCS in MPOmediated cardiovascular disease.
